[1]
2017. Efficacy of Apremilast on Quality-of-Life Measures in Patients with Moderate Plaque Psoriasis (UNVEIL Phase IV Study). SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s13. DOI:https://doi.org/10.25251/skin.1.supp.12.